CompletedNCT00302133
Naltrexone or placebo with valproate for alcohol use in bipolarity
About this title
Read the official source — NCT00302133Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- MiamiSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateMay 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 88
- Sponsor
- University of Miami
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00302133
- Official title
Show the full official title
Optimizing Pharmacotherapy for Bipolar Alcoholics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Miami
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Miami, a university.
Did this study involve medication?
Yes. The study involved medication, including Naltrexone hydrochloride.
Who was this study for?
Listed age limits: 18 years to 65 years.
